Upgrade to SI Premium - Free Trial

Stifel Reiterates Buy on Boston Scientific (BSX) Following 2Q

July 27, 2017 1:41 PM
Stifel reiterated a Buy rating and $32.00 price target on Boston Scientific (NYSE: BSX) following the company's 2Q. Revenue at ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS Change

Next Articles